TAO Synergies director granted 800 stock options

TAO Synergies Inc. director William S. Singer received a grant of stock options giving him the right to buy 800 shares of common stock.

Rhea-AI Filing Summary

TAO Synergies Inc. director William S. Singer received a grant of stock options giving him the right to buy 800 shares of common stock. The options have an exercise price of $5.52 per share and were granted at no cost.

All of these options vest and become exercisable upon completion of one year of service following April 7, 2026, and they expire on April 7, 2036. After this grant, Singer directly holds 800 stock options linked to TAO Synergies common shares.

Insider Trade Summary

Grant/Award: 800 shares

Grant/Award 1 txn

Insider Singer William S.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	800	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 800 contracts (Direct)

Footnotes (1)

1. F1. All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 7, 2026.

Key Figures

Options granted: 800 options Exercise price: $5.52 per share Grant price: $0.00 +2 more

5 metrics

Options granted 800 options Stock Option (Right to Buy) granted on April 7, 2026

Exercise price $5.52 per share Exercise price for underlying common stock

Grant price $0.00 Cost to receive the stock option award

Total options after grant 800 options Total derivative securities held following transaction

Expiration date April 7, 2036 Option expiration for the granted stock options

Key Terms

Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, expiration date, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

exercise price financial

"conversion_or_exercise_price: "5.5200""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2036-04-07T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vest and become immediately exercisable financial

"All of the holder's options shall vest and become immediately exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did TAO Synergies (TAOX) report for William S. Singer?

TAO Synergies reported that director William S. Singer received a grant of 800 stock options. These options give him the right to buy common shares at a fixed price as part of his compensation, rather than reflecting an open-market purchase or sale.

How many TAO Synergies (TAOX) stock options were granted and at what price?

William S. Singer was granted 800 TAO Synergies stock options with an exercise price of $5.52 per share. The grant price itself was $0.00, meaning he did not pay to receive the options but must pay $5.52 to exercise each one.

When do William S. Singer’s TAO Synergies (TAOX) options vest and expire?

All 800 options vest and become exercisable after William S. Singer completes one year of service following April 7, 2026. The options carry a long-term horizon and are scheduled to expire on April 7, 2036 if they are not exercised before that date.

Is the TAO Synergies (TAOX) Form 4 transaction a market buy or sell?

The Form 4 reflects a stock option grant, classified as a grant or award acquisition, not a market buy or sell. Singer received 800 options as compensation, and any future exercise or sale of shares would be reported in separate transactions.

How many TAO Synergies (TAOX) derivative securities does William S. Singer hold after this filing?

Following this transaction, William S. Singer directly holds 800 stock options linked to TAO Synergies common stock. The filing’s derivative summary shows no other derivative positions, so these 800 options represent his reported derivative holdings in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/08/2026 - 04:02 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Singer William S.

(Last) (First) (Middle)

C/O TAO SYNERGIES INC., 1185

AVENUE OF THE AMERICAS, 3RD FLOOR

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAO Synergies Inc. [ TAOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$5.52	04/07/2026		A		800		(1)	04/07/2036	Common Stock, par value $0.0001 per share	800	$0.00	800	D

Explanation of Responses:

1. All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 7, 2026.

	/s/ Robert Weinstein, Attorney-in-fact	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)